Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,275 | 11,192 | 24,803 | 20,159 | 34,598 |
| Marketable Securities | N/A | 282 | 272 | 12,993 | 12,453 |
| Receivables | 2,085 | 4,971 | 2,870 | 52 | 1,236 |
| Other current assets | 950 | 599 | 767 | 736 | 366 |
| TOTAL | $51,310 | $17,044 | $28,712 | $33,940 | $48,653 |
| Non-Current Assets | |||||
| PPE Net | 2,466 | 5,189 | 6,825 | 4,330 | 5,599 |
| Intangibles | 3,759 | 3,268 | 3,067 | 2,559 | 2,118 |
| Other Non-Current Assets | 2,492 | 35 | 35 | 35 | 38 |
| TOTAL | $8,717 | $8,492 | $9,927 | $6,923 | $7,755 |
| Total Assets | $60,027 | $25,536 | $38,638 | $40,863 | $56,408 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 77 | 74 | 71 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,381 | 2,014 | 3,026 | 1,402 | 1,862 |
| Accrued Expenses | 922 | 1,306 | 1,172 | 1,371 | 886 |
| Other current liabilities | 27,699 | 1,704 | 4,746 | 5,571 | N/A |
| TOTAL | $33,507 | $7,288 | $9,752 | $8,343 | $2,748 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,924 | 2,001 | 2,071 | N/A | N/A |
| Deferred Revenues | 3,428 | 2,190 | 738 | N/A | N/A |
| Other Non-Current Liabilities | 966 | 515 | 433 | 0 | 0 |
| TOTAL | $2,890 | $2,516 | $2,504 | $N/A | $N/A |
| Total Liabilities | $36,397 | $9,804 | $12,256 | $8,343 | $2,748 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,403 | 14,277 | 10,799 | 8,882 | 8,741 |
| Common Shares | 11 | 7 | 6 | 5 | 5 |
| Retained earnings | -275,469 | -250,310 | -226,358 | -199,190 | -172,648 |
| Other shareholders' equity | 0 | 0 | 0 | 18 | 13 |
| TOTAL | $23,630 | $15,732 | $26,382 | $32,519 | $53,660 |
| Total Liabilities And Equity | $60,027 | $25,536 | $38,638 | $40,863 | $56,408 |